Publications by authors named "Brandon Harder"

Claim this Profile
C
Comprehensive profiling of the human fecal proteome from IBD patients with DIA-MS enables evaluation of disease-relevant proteins.
Brandon J Harder, Annemarie N Lekkerkerker, Ellen P Casavant, Jason A Hackney, Allen Nguyen

Proteomics Clin Appl· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc).
Yanke Yu, Michael E Rothenberg, Han Ting Ding, Ari Brekkan, Gizette Sperinde, Brandon Harder

J Pharmacokinet Pharmacodyn· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis.
Frank Wagner, John C Mansfield, Annemarie N Lekkerkerker, Yehong Wang, Mary Keir, Brandon Harder

Gut· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatability.
Donna W Lee, Shelly Zhong, Rama Pai, Julie Rae, Siddharth Sukumaran, Brandon Harder

Pharmacol Res Perspect· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice recommendations for the transfer of cell-based assays for the measurement of neutralizing anti-drug antibodies.
Shelley S Belouski, Danika Born, Susan Jacques, Brandon Harder, Kai Reynhardt

Bioanalysis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-31 receptor (IL-31RA) knockout mice exhibit elevated responsiveness to oncostatin M.
Janine Bilsborough, Sherri Mudri, Eric Chadwick, Brandon Harder, Stacey R Dillon

J Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.
Stacey R Dillon, Brandon Harder, Kenneth B Lewis, Margaret D Moore, Hong Liu

Arthritis Res Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a high-affinity Fcgamma receptor by Ig-domain swapping between human CD64A and CD16A.
Jeff L Ellsworth, Nels Hamacher, Brandon Harder, Mark Maurer, Thomas R Bukowski

Protein Eng Des Sel· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis.
Jeff L Ellsworth, Nels Hamacher, Brandon Harder, Ken Bannink, Thomas R Bukowski

J Immunol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A).
Jeff L Ellsworth, Mark Maurer, Brandon Harder, Nels Hamacher, Megan Lantry

J Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.
Rolf E Kuestner, David W Taft, Aaron Haran, Cameron S Brandt, Ty Brender, Brandon Harder

J Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Sherine F Elsawa, Anne J Novak, Deanna M Grote, Steven C Ziesmer, Thomas E Witzig, Brandon Harder

Blood· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
Anne J Novak, Deanna M Grote, Steven C Ziesmer, Michael P Kline, Michelle K Manske, Brandon Harder

J Clin Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
Janine Bilsborough, Donald Y M Leung, Mark Maurer, Michael Howell, Mark Boguniewicz, Brandon Harder

J Allergy Clin Immunol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Anne J Novak, Deanna M Grote, Mary Stenson, Steven C Ziesmer, Thomas E Witzig, Brandon Harder

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.
Stacey R Dillon, Cindy Sprecher, Angela Hammond, Janine Bilsborough, Maryland Rosenfeld-Franklin, Brandon Harder

Nat Immunol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Anne J Novak, Jaime R Darce, Bonnie K Arendt, Brandon Harder, Kathy Henderson

Blood· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis